Resource Utilisation And Related Health Care Costs Among Patients With Multiple Myeloma With ≥ 2 Prior Lines Of Treatment In Finland: Evaluation Based On Finnish Real World Data From Auria Biobank



: Kosunen M, Kurki S, Snicker K, Wiik E

: 2017

 Value in Health

: 20

: 9

DOI: https://doi.org/10.1016/j.jval.2017.08.567


To analyse resource utilisation and related health care costs among
patients with multiple myeloma (MM) with ≥ 2 prior lines of treatment
based on the patients’ serum monoclonal protein in Finland.



Last updated on 26/11/2024 09:30:23 PM